Company Search:
Advanced Search
Sponsored Links
Paradigm Biopharmaceuticals Ltd Company Snapshot
Paradigm Biopharmaceuticals Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Paradigm Biopharmaceuticals Ltd with three other companies in this sector in AUSTRALIA : Adalta Ltd (2020 sales of 3.85 million Australian Dollars [US$2.78 million] ), Pharmaust Limited (4.12 million Australian Dollars [US$2.98 million] ), and Acrux Ltd (3.95 million Australian Dollars [US$2.85 million] of which 22% was Lenezetto).

Sales Analysis. Paradigm Biopharmaceuticals Ltd reported sales of A$4.70 million (US$3.39 million) for the fiscal year ending June of 2020. This represents an increase of 44.7% versus 2019, when the company's sales were A$3.25 million. Sales at Paradigm Biopharmaceuticals Ltd have increased during each of the previous five years (and since 2015, sales have increased a total of 63,950%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Paradigm Biopharmaceuticals Ltd
  Stock Performance Chart for Paradigm Biopharmaceuticals Ltd
  Stock Data: Recent Stock Performance:
  Current Price (9/18/2020): 2.50
(Figures in Australian Dollars)
1 Week -0.4%   13 Weeks -11.3%  
4 Weeks -25.4%   52 Weeks 9.2%  
Paradigm Biopharmaceuticals Ltd Key Data:
  Ticker: PAR Country: Australia
  Exchanges: ASX Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 4,695,494
(Year Ending Jan 2021).
Employees: N/A
  Currency: Australian Dollars Market Cap: 561,867,940
  Fiscal Yr Ends: June Shares Outstanding: 224,747,176
  Share Type: Ordinary Closely Held Shares: 42,597,831
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.